Understanding the Underutilization of Germline Genetic Testing in ...

Below are 4 principles for providers to understand how to implement germline genetic testing for all patients with prostate cancer.

germline testing for prostate cancer, universal genetic germline testing, genetic counseling in prostate cancer, democratizing genetic ...

Understanding the Underutilization of Germline Genetic Testing in ...

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer July 12, 2023. Neal Shore, MD, FACS; David Wise, MD, PhD; ...

Invitae on LinkedIn: Understanding the Underutilization of Germline ...

Hot off the #ASCODailyNews press: “Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer” Neal Shore, David Wise, MD PhD, and…

Neal Shore on LinkedIn: Understanding the Underutilization of ...

Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer #prostatecancer.

The PROCLAIM Trial - Beyond the Abstract - UroToday

Shore, N., Wise, D. & Young, S. N. Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer. ASCO Daily News (2023).

Access disparities and underutilization of germline genetic testing in ...

In our cohort, 15% of BC patients who met NCCN criteria for germline testing were effectively tested. This percentage was even lower at the ...

Few People with Cancer Undergo Germline Testing - NCI

Testing among people with other cancers possibly associated with germline gene mutations was much less common. About 6% of people with ...

PD13-03 LACK OF AWARENESS AND UNDERUTILIZATION OF ...

Germline genetic factors are playing an increasingly important role in the management of many cancers, including breast, ovarian and prostate ...

Real-world data point to underutilization of germline, somatic testing ...

A total of 59.2% (n=590) received HRRm testing, of which 19.8% (n=117) underwent germline testing; 59.8% (n=353) underwent somatic testing; and ...

underutilization - Myrtle Beach - Carolina Urologic Research Center

You are here: Home1 / Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer2 / underutilization. underutilization.

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient ...

Genetic evaluation is underutilized in PCA and digital webtools may help expand access to pretest informed decision-making for germline testing.

Underutilization of germline BRCA testing in commercially-insured ...

Future studies should examine barriers to timely genetic testing and identify scalable strategies for increasing testing in women with ovarian cancer, ...

Persistent Underutilization of BRCA Testing for Breast and Ovarian ...

Two recent studies document ongoing underutilization and disparities in genetic testing for patients with breast and ovarian cancer.

UroToday.com on X: "Understanding the underutilization of germline ...

Understanding the underutilization of germline genetic testing in #ProstateCancer. Sarah Young & David Wise join Neal Shore to discuss ...

Germline Genetic Testing After Cancer Diagnosis - JAMA Network

The primary outcome was germline genetic testing within 2 years of the cancer diagnosis. Tests performed later are less consistently related to ...

Enhanced Clinical Education and Simplified Guidelines Needed to ...

Although the use of precision oncology has transformed breast cancer management, there is a notable under-utilization of germline testing in ...

Germline Testing in Prostate Cancer: When and Who to Test

Increasing demand for germline testing in prostate cancer and a shortage of genetic counselors have created a need for alternative care models ...

Huge Underuse of Germline Testing for Cancer Patients - Medscape

Rates of germline genetic testing for patients newly diagnosed with common cancers are far below recommended levels, prompting calls for ...

Clinical Utility of Universal Germline Genetic Testing for Patients ...

Importance National Comprehensive Cancer Network guidelines currently recommend germline testing for high-risk genes in selected patients with ...